261 related articles for article (PubMed ID: 11851742)
1. Management of the upper limb with botulinum toxin type A in children with spastic type cerebral palsy and acquired brain injury: clinical implications.
Autti-Rämö I; Larsen A; Taimo A; von Wendt L
Eur J Neurol; 2001 Nov; 8 Suppl 5():136-44. PubMed ID: 11851742
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin type A injections in the spastic upper extremity of children with hemiplegia: child characteristics that predict a positive outcome.
Fehlings D; Rang M; Glazier J; Steele C
Eur J Neurol; 2001 Nov; 8 Suppl 5():145-9. PubMed ID: 11851743
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin-a in children with congenital spastic hemiplegia does not improve upper extremity motor-related function over rehabilitation alone: a randomized controlled trial.
Rameckers EA; Speth LA; Duysens J; Vles JS; Smits-Engelsman BC
Neurorehabil Neural Repair; 2009; 23(3):218-25. PubMed ID: 19106252
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.
Wasiak J; Hoare B; Wallen M
Cochrane Database Syst Rev; 2004 Oct; (4):CD003469. PubMed ID: 15495055
[TBL] [Abstract][Full Text] [Related]
5. The effect of botulinum toxin type A on the functional ability of the child with spastic hemiplegia a randomized controlled trial.
Love SC; Valentine JP; Blair EM; Price CJ; Cole JH; Chauvel PJ
Eur J Neurol; 2001 Nov; 8 Suppl 5():50-8. PubMed ID: 11851734
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of botulinum toxin A in upper limb function of hemiplegic patients.
Rousseaux M; Kozlowski O; Froger J
J Neurol; 2002 Jan; 249(1):76-84. PubMed ID: 11954872
[TBL] [Abstract][Full Text] [Related]
7. A randomized study of combined botulinum toxin type A and casting in the ambulant child with cerebral palsy using objective outcome measures.
Desloovere K; Molenaers G; Jonkers I; De Cat J; De Borre L; Nijs J; Eyssen M; Pauwels P; De Cock P
Eur J Neurol; 2001 Nov; 8 Suppl 5():75-87. PubMed ID: 11851736
[TBL] [Abstract][Full Text] [Related]
8. Medium-term functional benefits in children with cerebral palsy treated with botulinum toxin type A: 1-year follow-up using gross motor function measure.
Linder M; Schindler G; Michaelis U; Stein S; Kirschner J; Mall V; Berweck S; Korinthenberg R; Heinen F
Eur J Neurol; 2001 Nov; 8 Suppl 5():120-6. PubMed ID: 11851740
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.
Lukban MB; Rosales RL; Dressler D
J Neural Transm (Vienna); 2009 Mar; 116(3):319-31. PubMed ID: 19142573
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of multiple botulinum toxin sessions and the duration of effects in spasticity therapy in children with cerebral palsy.
Mirska A; Kułak W; Okurowska-Zawada B; Dmitruk E
Childs Nerv Syst; 2019 Jan; 35(1):141-147. PubMed ID: 30058050
[TBL] [Abstract][Full Text] [Related]
11. Use of three-dimensional kinematic analysis following upper limb botulinum toxin A for children with hemiplegia.
Mackey AH; Miller F; Walt SE; Waugh MC; Stott NS
Eur J Neurol; 2008 Nov; 15(11):1191-8. PubMed ID: 18727674
[TBL] [Abstract][Full Text] [Related]
12. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.
Wasiak J; Hoare B; Wallen M
Cochrane Database Syst Rev; 2004; (3):CD003469. PubMed ID: 15266487
[TBL] [Abstract][Full Text] [Related]
14. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population.
Pandyan AD; Vuadens P; van Wijck FM; Stark S; Johnson GR; Barnes MP
Clin Rehabil; 2002 Sep; 16(6):654-60. PubMed ID: 12392341
[TBL] [Abstract][Full Text] [Related]
15. Kinematic aiming task: measuring functional changes in hand and arm movements after botulinum toxin-A injections in children with spastic hemiplegia.
Rameckers EA; Speth LA; Duysens J; Vles JS; Smits-Engelsman BC
Am J Phys Med Rehabil; 2007 Jul; 86(7):538-47. PubMed ID: 17581288
[TBL] [Abstract][Full Text] [Related]
16. Effect of addition of botulinum toxin-A to standardized therapy for dynamic manual skills measured with kinematic aiming tasks in children with spastic hemiplegia.
Rameckers EA; Duysens J; Speth LA; Vles HJ; Smits-Engelsman BC
J Rehabil Med; 2010 Apr; 42(4):332-8. PubMed ID: 20461335
[TBL] [Abstract][Full Text] [Related]
17. Effects of ultrasound-guided botulinum toxin type-A injections with a specific approach in spastic cerebral palsy.
Büyükavcı R; Büyükavcı MA
Acta Neurol Belg; 2018 Sep; 118(3):429-433. PubMed ID: 29694645
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin type A injection for management of upper limb spasticity in children with cerebral palsy: a literature review.
Park ES; Rha DW
Yonsei Med J; 2006 Oct; 47(5):589-603. PubMed ID: 17066503
[TBL] [Abstract][Full Text] [Related]
19. Combined therapy using botulinum toxin A and single-joint hybrid assistive limb for upper-limb disability due to spastic hemiplegia.
Saita K; Morishita T; Hyakutake K; Fukuda H; Shiota E; Sankai Y; Inoue T
J Neurol Sci; 2017 Feb; 373():182-187. PubMed ID: 28131185
[TBL] [Abstract][Full Text] [Related]
20. Safety profile of incobotulinum toxin A [Xeomin(®)] in gastrocnemious muscles injections in children with cerebral palsy: Randomized double-blind clinical trial.
Carraro E; Trevisi E; Martinuzzi A
Eur J Paediatr Neurol; 2016 Jul; 20(4):532-7. PubMed ID: 27177451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
